Cachexia Worsens Prognosis in Patients with Resectable Pancreatic Cancer
暂无分享,去创建一个
H. Friess | M. Büchler | M. Martignoni | J. Bachmann | Holger Krakowski-Roosen | Mathias Heiligensetzer | Jeannine Bachmann
[1] H. Friess,et al. Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] Hiroyuki Aburatani,et al. Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.
[3] Daniel F Hayes,et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Christoph Michalski,et al. Pancreatic Cancer: From Bench to 5-Year Survival , 2006, Pancreas.
[5] P. Glare. Clinical predictors of survival in advanced cancer. , 2005, The journal of supportive oncology.
[6] H. Kitagawa,et al. Pancreas Head Carcinoma: Frequency of Invasion to Soft Tissue Adherent to the Superior Mesenteric Artery , 2005, The American journal of surgical pathology.
[7] S. Wigmore,et al. Systemic inflammation, cachexia and prognosis in patients with cancer , 2005, Current opinion in clinical nutrition and metabolic care.
[8] A. Inui,et al. Therapy Insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself , 2005, Nature Clinical Practice Oncology.
[9] M. Imamura,et al. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. , 2004, Surgery.
[10] J. Neoptolemos,et al. Current standards of surgery for pancreatic cancer , 2004, The British journal of surgery.
[11] S. Saglam,et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] H. Friess,et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma , 2004, The British journal of surgery.
[13] J. Bauer,et al. Weight stabilisation is associated with improved survival duration and quality of life in unresectable pancreatic cancer. , 2004, Clinical nutrition.
[14] Helen Hickey,et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.
[15] K. Fearon,et al. Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids , 2004, British Journal of Cancer.
[16] S. Dudrick,et al. What We Have Learned about Cachexia in Gastrointestinal Cancer , 2003, Digestive Diseases.
[17] F. Gansauge,et al. Treatment of Pancreatic Cancer: Challenge of the Facts , 2003, World Journal of Surgery.
[18] P. Costelli,et al. Mechanisms of skeletal muscle depletion in wasting syndromes: role of ATP‐ubiquitin‐dependent proteolysis , 2003, Current opinion in clinical nutrition and metabolic care.
[19] M. Schäfer,et al. Evidence-Based Pancreatic Head Resection for Pancreatic Cancer and Chronic Pancreatitis , 2002, Annals of surgery.
[20] H. Friess,et al. Surgical approaches for resection of pancreatic cancer: an overview. , 2002, Hepatobiliary & pancreatic diseases international : HBPD INT.
[21] I. Bosaeus,et al. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients , 2001, International journal of cancer.
[22] M. Tisdale,et al. Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF) , 2001, British Journal of Cancer.
[23] A. Richter,et al. Personal observations, opinions, and approaches to cancer of the pancreas and the periampullary area. , 2001, The Surgical clinics of North America.
[24] S. Meijsing,et al. Cancer cachexia: A therapeutic approach , 2001, Medicinal research reviews.
[25] M. Tisdale. Metabolic abnormalities in cachexia and anorexia. , 2000, Nutrition.
[26] K. Nelson. Modern management of the cancer anorexia—cachexia syndrome , 2000, Current pain and headache reports.
[27] H. Friess,et al. Pancreatic fistula after pancreatic head resection , 2000, The British journal of surgery.
[28] A. Nakao. Oncological problems in pancreatic cancer surgery. , 2000, Nagoya journal of medical science.
[29] A. Inui,et al. Cancer anorexia-cachexia syndrome: are neuropeptides the key? , 1999, Cancer research.
[30] C. Ripamonti,et al. Management of dyspnea in advanced cancer patients , 1999, Supportive Care in Cancer.
[31] D. McMillan,et al. Pancreatic Cancer as a Model: Inflammatory Mediators, Acute-phase Response, and Cancer Cachexia , 1999, World Journal of Surgery.
[32] S. Matsuno,et al. Staging systems for pancreatic cancer: differences between the Japanese and UICC systems. , 1998, Journal of hepato-biliary-pancreatic surgery.
[33] H. Friess,et al. [Prognosis in pancreatic carcinoma]. , 1996, Therapeutische Umschau. Revue therapeutique.
[34] D. Klimstra,et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.
[35] A. Andrén-sandberg,et al. Total Pancreatectomy for Cancer of the Pancreas: Is It Appropriate? , 1996, World Journal of Surgery.
[36] W. Gaus,et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis , 1996, The British journal of surgery.
[37] C. Wittekind,et al. TNM Klassifikation maligner Tumoren , 1987 .
[38] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[39] M. Dank. [Tumorus anorexia/cachexia syndrome] , 2001, Magyar onkologia.
[40] D. Klimstra,et al. Results of total pancreatectomy for adenocarcinoma of the pancreas. , 2001, Archives of surgery.
[41] J. Kleeff,et al. DIE PROGNOSE DES PANKREASKARZINOMS , 1996 .